Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
William P Katt, Cody Aplin & Richard A Cerione. (2022) Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives. OncoTargets and Therapy 15, pages 277-290.
Read now
Read now
Jeffrey W. Keillor & Gail V.W. Johnson. (2021) Transglutaminase 2 as a therapeutic target for neurological conditions. Expert Opinion on Therapeutic Targets 25:9, pages 721-731.
Read now
Read now
Yi Zhang & Benjamin K. Simpson. (2020) Food-related transglutaminase obtained from fish/shellfish. Critical Reviews in Food Science and Nutrition 60:19, pages 3214-3232.
Read now
Read now
Articles from other publishers (27)
Cong Liu, Xing Gao, Ruo‐Xi Shi, Ying‐Ying Wang, Xuan‐Cheng He, Hong‐Zhen Du, Baoyang Hu, Jianwei Jiao, Chang‐Mei Liu & Zhao‐Qian Teng. (2023) Microglial transglutaminase 2 deficiency causes impaired synaptic remodelling and cognitive deficits in mice. Cell Proliferation 56:9.
Crossref
Crossref
Pratibha Sharma & Manjinder Singh. (2023) An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects. Life Sciences 320, pages 121568.
Crossref
Crossref
Doa’a G. F. Al-U’datt, Carole C. Tranchant, Belal Al-Husein, Roddy Hiram, Ahmed Al-Dwairi, Mohammad AlQudah, Othman Al-shboul, Saied Jaradat, Jenan Alqbelat & Ali Almajwal. (2023) Involvement and possible role of transglutaminases 1 and 2 in mediating fibrotic signalling, collagen cross-linking and cell proliferation in neonatal rat ventricular fibroblasts. PLOS ONE 18:2, pages e0281320.
Crossref
Crossref
Claudia Damaris Müller, Gloria Ruiz-Gómez, Sophie Cazzonelli, Stephanie Möller, Robert Wodtke, Reik Löser, Joanna Freyse, Jan-Niklas Dürig, Jörg Rademann, Ute Hempel, M. Teresa Pisabarro & Sarah Vogel. (2022) Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation. Scientific Reports 12:1.
Crossref
Crossref
Alana M. M. Rangaswamy, Pauline Navals, Eric W. J. Gates, Sammir Shad, Sarah K. I. Watt & Jeffrey W. Keillor. (2022) Structure–activity relationships of hydrophobic alkyl acrylamides as tissue transglutaminase inhibitors. RSC Medicinal Chemistry 13:4, pages 413-428.
Crossref
Crossref
Nicole M.R. McNeil, Eric W.J. Gates, Neda Firoozi, Nicholas J. Cundy, Jessica Leccese, Sarah Eisinga, Joel D.A. Tyndall, Gautam Adhikary, Richard L. Eckert & Jeffrey W. Keillor. (2022) Structure-activity relationships of N-terminal variants of peptidomimetic tissue transglutaminase inhibitors. European Journal of Medicinal Chemistry 232, pages 114172.
Crossref
Crossref
Jie Zhang, HilaryGrosso Jasutkar & MMaral Mouradian. (2021) Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies. Neural Regeneration Research 16:8, pages 1560.
Crossref
Crossref
Regina Staffler, Ralf Pasternack, Martin Hils, Wolfgang Kaiser & Friederike M. Möller. (2020) Nucleotide binding kinetics and conformational change analysis of tissue transglutaminase with switchSENSE. Analytical Biochemistry 605, pages 113719.
Crossref
Crossref
Kinga Lénárt, Attila Pap, Róbert Pórszász, Anna V. Oláh, László Fésüs & András Mádi. (2020) Transglutaminase 2 Has Metabolic and Vascular Regulatory Functions Revealed by In Vivo Activation of Alpha1-Adrenergic Receptor. International Journal of Molecular Sciences 21:11, pages 3865.
Crossref
Crossref
Ruize Zhuang & Chaitan Khosla. (2020) Substrates, inhibitors, and probes of mammalian transglutaminase 2. Analytical Biochemistry 591, pages 113560.
Crossref
Crossref
Ralf Pasternack, Christian Büchold, Robert Jähnig, Christiane Pelzer, Michael Sommer, Andreas Heil, Peter Florian, Götz Nowak, Uwe Gerlach & Martin Hils. (2020) Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a). Journal of Thrombosis and Haemostasis 18:1, pages 191-200.
Crossref
Crossref
Ludvig M. Sollid & Knut E.A. Lundin. 2020. The Autoimmune Diseases. The Autoimmune Diseases
849
869
.
Laszlo Lorand & Siiri E. Iismaa. (2018) Transglutaminase diseases: from biochemistry to the bedside. The FASEB Journal 33:1, pages 3-12.
Crossref
Crossref
William P. Katt, Nicolas J. Blobel, Svetlana Komarova, Marc A. Antonyak, Ichiro Nakano & Richard A. Cerione. (2018) A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells. Oncotarget 9:76, pages 34379-34397.
Crossref
Crossref
Brad A. Palanski & Chaitan Khosla. (2018) Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism. Biochemistry 57:24, pages 3359-3363.
Crossref
Crossref
Robert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, Elisabeth Jäckel, David Bauer, Martin Lohse, Alan Wong, Johanna Pufe, Friedrich-Alexander Ludwig, Steffen Fischer, Sandra Hauser, Dieter Greif, M. Teresa Pisabarro, Jens Pietzsch, Markus Pietsch & Reik Löser. (2018)
N
ε
-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure–Activity Relationships, and Pharmacokinetic Profiling
. Journal of Medicinal Chemistry 61:10, pages 4528-4560.
Crossref
Crossref
Elizabeth Reyna-Beltrán, María Iranzo, Karla Grisel Calderón-González, Ricardo Mondragón-Flores, María Luisa Labra-Barrios, Salvador Mormeneo & Juan Pedro Luna-Arias. (2018) The Candida albicans ENO1 gene encodes a transglutaminase involved in growth, cell division, morphogenesis, and osmotic protection. Journal of Biological Chemistry 293:12, pages 4304-4323.
Crossref
Crossref
Marsha C. Lampi & Cynthia A. Reinhart-King. (2018) Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials. Science Translational Medicine 10:422.
Crossref
Crossref
Lei Zhang, Wenbing Rao, Solange Muhayimana, Xianfei Zhang, Jiuyong Xu, Ciying Xiao & Qingchun Huang. (2018) Purification and biochemical characterization of a novel transglutaminase from Mythimna separata larvae (Noctuidae, Lepidoptera). Journal of Biotechnology 265, pages 1-7.
Crossref
Crossref
Will W. Minuth. (2017) Concepts for a therapeutic prolongation of nephrogenesis in preterm and low-birth-weight babies must correspond to structural-functional properties in the nephrogenic zone. Molecular and Cellular Pediatrics 4:1.
Crossref
Crossref
Abdullah Akbar, Nicole M. R. McNeil, Marie R. Albert, Viviane Ta, Gautam Adhikary, Karine Bourgeois, Richard L. Eckert & Jeffrey W. Keillor. (2017) Structure–Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase. Journal of Medicinal Chemistry 60:18, pages 7910-7927.
Crossref
Crossref
Zsuzsa Szondy, Ilma Korponay-Szabó, Robert Király, Zsolt Sarang & Gregory J. Tsay. (2017) Transglutaminase 2 in human diseases. BioMedicine 7:3, pages 15.
Crossref
Crossref
E. Teran-Hinojosa, H. Sobral, C. Sánchez-Pérez, A. Pérez-García, N. Alemán-García & J. Hernández-Ruiz. (2017) Differentiation of fibrotic liver tissue using laser-induced breakdown spectroscopy. Biomedical Optics Express 8:8, pages 3816.
Crossref
Crossref
Chaitan Khosla. (2017) Celiac Disease: Lessons for and from Chemical Biology. ACS Chemical Biology 12:6, pages 1455-1459.
Crossref
Crossref
Minsoo Song, Hayoung Hwang, Chun Young Im & Soo-Youl Kim. (2016) Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors. Journal of Medicinal Chemistry 60:2, pages 554-567.
Crossref
Crossref
Aaron Lerner, Rustam Aminov & Torsten Matthias. (2017) Transglutaminases in Dysbiosis As Potential Environmental Drivers of Autoimmunity. Frontiers in Microbiology 8.
Crossref
Crossref
Nicola Gaetano Gatta, Rosaria Romano, Elenamaria Fioretti & Vittorio Gentile. (2017) Transglutaminase inhibition: possible therapeutic mechanisms to protect cells from death in neurological disorders. AIMS Molecular Science 4:4, pages 399-414.
Crossref
Crossref